Tagged / collaborative research

Another CMMPH COVID-19 publication on fathers

Congratulations to Centre for Midwifery, Maternal & Perinatal Health (CMMPH) Visiting Faculty members Prof. Minesh Khashu and Ms. Jillian Ireland on the acceptance of their paper “COVID-19 restrictions and psychological well-being of fathers with infants admitted to NICU (neonatal intensive care units)—an exploratory cross-sectional study” has been accepted by Acta Paediatrica [1]. Acta Paediatrica

These authors, both employed by University Hospitals Dorset NHS Foundation Trust, are part of an international team of researchers studying the role of fathers in maternity care.  The first author on the paper, Dr. Esther Adama is Lecturer in the School of Nursing and Midwifery at Edith Cowan University in Australia. Previous papers produced by some members of this team were both published in the Journal of Neonatal Nursing [2-3].

Congratulations to my colleagues!

Prof. Edwin van Teijlingen

 

 

References:

  1. Adama E.A., Koliouli F., Provenzi L., Feeley N., van Teijlingen E., Ireland J., Thomson-Salo F., Khashu M and FINESSE Group (2022) COVID-19 restrictions and psychological well-being of fathers with infants admitted to NICU—an exploratory cross-sectional study, Acta Paediatrica (accepted).
  2. Fisher, D., Khashu, M., Adama, E., Feeley, N., Garfield, C., Ireland, J., Koliouli F., Lindberg, B., Noergaard, B., Provenzi, L., Thomson-Salo, F., van Teijlingen, E. (2018) Fathers in neonatal units: Improving infant health by supporting the baby-father bond & mother-father co-parenting, Journal of Neonatal Nursing 24(6): 306-312 https://doi.org/10.1016/j.jnn.2018.08.007
  3. Ireland, J., Khashu, M., Cescutti-Butler, L., van Teijlingen, E., Hewitt-Taylor, J. (2016) Experiences of fathers with babies admitted to neonatal care units: A review of literature, Journal of Neonatal Nursing 22(4): 171–176

RKEDF Clinical Research Governance Sessions

As you will be aware, RDS offers something called the RKEDF, or Research & Knowledge Exchange Development Framework – as part of this there are a number of sessions available surrounding clinical research governance. These sessions can be booked as a 1:2:1 or in bespoke group sessions with Suzy Wignall, BU’s Clinical Governance Advisor.

As always, general chats/specific discussions can also be booked in too – please just email!

The RKEDF sessions available are as follows:

Please get in touch if you are interested in any of these sessions.

For general guidance, documents and further information surrounding processes, take a look at the Clinical Governance website.

Another research league table

This week Research.com, a prominent academic platform, published its 2022 Edition of the Ranking of Top 1000 Scientists in the area of Social Sciences and Humanities.  Professor Edwin van Teijlingen, in the Centre for Midwifery, Maternal & Perinatal Health (CMMPH), is listed as number 234 in United Kingdom ranking as well as number 1238 in the Social Sciences and Humanities world ranking.

 

Two new academic papers on COVID-19 research

This month CMMPH has two new research papers focusing on COVID-19.   The first one published in World Medical & Health Policy reports on a quantitative study of the availability of hand-washing facilities in households across Nepal [1].  This study used secondary data from Nepal Demographic Health Survey (NDHS) 2016 to assess the association between households’ wealth status to handwashing stations. The findings reported a statistically significant association between age of the household head, residence place, ecological zone, province, wealth status, having of mosquito net, having a radio, and TV at respondents’ household to fixed hand-washing stations at their households.

The second paper published three days ago in Vaccines is a qualitative study of of interviews with Nepali immigrants living in the UK and their attitudes towards COVD-19 vaccination [2].  Vaccination saves lives and can be an effective strategy for preventing the spread of the COVID-19, but negative attitudes towards vaccines lead to vaccine hesitancy. This study aimed to explore the factors influencing the uptake of the COVID-19 vaccine in the Nepali community in the UK. This study found that attitudes towards COVID-19 are generally positive. Nine overlapping themes around barriers to COVID-19 vaccination were identified: (a) rumours and mis/disinformation; (b) prefer home remedies and yoga; (c) religion restriction; (d) concern towards vaccine eligibility; (e) difficulty with online vaccine booking system; (f) doubts of vaccine effectiveness after changing the second dose timeline; (g) lack of confidence in the vaccine; (h) past bad experience with the influenza vaccine; and (i) worried about side-effects. Understanding barriers to the uptake of the COVID-19 vaccine can help in the design of better targeted interventions. Public health messages including favourable policy should be tailored to address those barriers and make this vaccination programme more viable and acceptable to the ethnic minority communities in the UK.   This Vaccine paper includes two FHSS Visiting Faculty as co-authors: Prof. Padam Simkhada and Dr. Bibha Simkhada.

 

Prof. Edwin van Teijlingen

 

 

 

 

 

References:

  1. Sharma, M., Adhikari, R., van Teijlingen, E. (2022) Handwashing station in Nepal: Role of wealth status in establishing a handwashing station, World Medical & Health Policy Accepted
  2. Simkhada, P., Tamang, P., Timilsina, L., Simkhada, B., Bissell, P., van Teijlingen, E., Sah, S.K., Wasti, S.P. (2022) Factors Influencing COVID-19 Vaccine Uptake among Nepali in the UK: A Qualitative Study, Vaccine 10(5), 780;https://doi.org/10.3390/vaccines10050780

Summit of Health & Population Scientists in Nepal 2022

Today say the start of the Eight National Summit of Health & Population Scientists in Nepal.  Bournemouth University is involved in two presentation.  The first will be one by University of Huddersfield PhD student Tamang Pasang, and her supervisors Prof. Padam Simkhada (FHSS Visiting Faculty), Dr. Bibha Simkhada (former BU Lecturer in Nursing and current FHSS Visiting Faculty) and Prof. Edwin van Teijlingen.  Pasang will be talking about her thesis fieldwork: ‘Impact of Federalisation in Maintaining Quality of Maternal and Neonatal Care in Nepalese Health System’.

The second presentation will focus of the Nepal Federal Health System Project, our major collaborative project examining the consequences for the health system of Nepal’s move to a federal government structure in 2015.  This is a joint project led by the University of Sheffield with Bournemouth University, the University of Huddersfield, and two institutions in Nepal: Manmohan Memorial Institute of Health Sciences MMIHS) and PHASE Nepal.  This interdisciplinary study is funded by the UK Health Systems Research Initiative [Grant ref.
MR/T023554/1]. 

Prof. Edwin van Teijlingen

Centre for Midwifery, Maternity & Perinatal Health (CMMPH)

 

 

Elsevier-UK Institutions Agreement

Elsevier and Jisc have established an agreement to enable continued reading access for UK researchers and to enable open access publishing. When publishing in eligible Elsevier journals, authors will be able to choose to publish open access at no additional cost to the author.

This agreement is effective until the end of December 2024.

This agreement supports corresponding authors affiliated with a Jisc participating institution (which BU is), regardless of the department in which they work.

Authors who publish under this agreement can:

  • Publish their peer-reviewed research open access in hybrid journals, at no charge to the author.
  • Publish their peer-reviewed research in fully gold open access journals at a discount on the list price APC.
  • Publish eligible articles in a wide variety of participating Elsevier journals across disciplines.
  • Rely on high-quality peer-review and experienced editorial support.

You can search for whether the intended journal falls under the agreement here.

Eligibility criteria

  • The author must be the submitting corresponding author affiliated with an eligible institution
  • Articles must have an acceptance date between 1.1.2022 and 31.12.2024

Instructions for corresponding authors

  • Once your article has been accepted for publication in a participating journal, you will receive an email containing a link to the “post-acceptance author journey”. Upon selecting your publishing options, your affiliation will be validated by your institution, and you will be informed if the APC will be covered by the agreement.
  • Upon publication, your final published open access article will be made freely available on ScienceDirect, the world’s largest publishing platform.

Other open access publishing options for authors

Authors can continue to choose to publish under the subscription model and self-archive their manuscript (Green Open Access) in line with Elsevier’s sharing policy.


Details of this agreement and others which BU holds with publishers such as Wiley and Springer, can be found here. Any queries, please contact openaccess@bournemouth.ac.uk

Elsevier-UK Institutions Agreement

Elsevier and Jisc have established an agreement to enable continued reading access for UK researchers and to enable open access publishing. When publishing in eligible Elsevier journals, authors will be able to choose to publish open access at no additional cost to the author.

This agreement is effective until the end of December 2024.

This agreement supports corresponding authors affiliated with a Jisc participating institution (which BU is), regardless of the department in which they work.

Authors who publish under this agreement can:

  • Publish their peer-reviewed research open access in hybrid journals, at no charge to the author.
  • Publish their peer-reviewed research in fully gold open access journals at a discount on the list price APC.
  • Publish eligible articles in a wide variety of participating Elsevier journals across disciplines.
  • Rely on high-quality peer-review and experienced editorial support.

You can search for whether the intended journal falls under the agreement here.

Eligibility criteria

  • The author must be the submitting corresponding author affiliated with an eligible institution
  • Articles must have an acceptance date between 1.1.2022 and 31.12.2024

Instructions for corresponding authors

  • Once your article has been accepted for publication in a participating journal, you will receive an email containing a link to the “post-acceptance author journey”. Upon selecting your publishing options, your affiliation will be validated by your institution, and you will be informed if the APC will be covered by the agreement.
  • Upon publication, your final published open access article will be made freely available on ScienceDirect, the world’s largest publishing platform.

Other open access publishing options for authors

Authors can continue to choose to publish under the subscription model and self-archive their manuscript (Green Open Access) in line with Elsevier’s sharing policy.


Details of this agreement and others which BU holds with publishers such as Wiley and Springer, can be found here. Any queries, please contact openaccess@bournemouth.ac.uk

Social Work Research cited in national newspaper

Congratulations to Dr. Orlanda Harvey who was cited last week in The Daily Telegraph in an article with the underlying question whether Vladimir Putin is experiencing so-called “roid rage” from steroid treatment.  This theory has been suggested by by Western intelligence services.  Orlanda’s PhD study at Bournemouth University focused on men using anabolic androgenic steroids for non-medical use.  She published several academic papers on the topic [1-3].

References:

  1. Harvey, O., Parrish, M., van Teijlingen, E, Trenoweth, S. (2021) Libido as a reason to use non-prescribed Anabolic Androgenic Steroids, Drugs: Education, Prevention & Policy (online first). https://doi.org/10.1080/09687637.2021.1882940
  2. Harvey, O., Parrish, M., van Teijlingen, E.Trenoweth, S. (2020) Support for non-prescribed Anabolic Androgenic Steroids users: A qualitative exploration of their needs Drugs: Education, Prevention & Policy 27:5, 377-386. doi 10.1080/09687637.2019.1705763
  3. Harvey, O., Keen, S., Parrish, M., van Teijlingen, E. (2019) Support for people who use Anabolic Androgenic Steroids: A Systematic Literature Review into what they want and what they access. BMC Public Health 19: 1024 https://doi.org/10.1186/s12889-019-7288-x https://rdcu.be/bMFon

Good UK – Horizon Europe News

According to Research Professional, UK government has extended a financial “safety net” for successful UK applicants to Horizon Europe (HEU). This follows last November’s guarantee for the limited number of “first wave” of funding calls from the European Union’s €95.5 billion (£80.5bn) R&D programme.

On 15 March, 2022 science minister George Freeman extended the guarantee to awards that are expected to be signed by the end of December 2022, while efforts continued to associate to the programme. The announcement comes after yesterday’s news that the business department has allocated £6.8 billion for EU programmes during 2022-2025, supporting the UK’s eventual association with Horizon Europe, Euratom Research and Training, and Fusion for Energy.

The extension now covers “all eligible, current applications to calls where researchers expect to sign grant agreements this year” but are unable to do so due to the ongoing delays to formalising UK association. Full details of the scope and terms of the extended guarantee are available on the UKRI website.

As usual, we encourage BU academics to apply for next Horizon Europe calls. To discuss more details about your potential HEU project, please get in touch with RDS Research Facilitator International Ainar Blaudums or your allocated Funding Development Officer.

EU funding related events – March / April 2022

COST webinar

UKRO will be holding a webinar ‘An Introduction to COST” on 17 March 2022 (11:00-12:30pm UK time). COST (European Cooperation in Science and Technology) is a funding organisation that aims to support researchers, in any sector and at all career stages, to grow their professional research networks and boost their careers. COST Actions are open to all science and technology fields, including new and emerging fields and help to connect research initiatives across Europe and beyond.

The webinar is aimed at researchers and research support staff, interested in finding out more about COST funding opportunities. The event will also outline the different ways to get involved in a COST action and will cover UK participation in COST. Attendance is free of charge, but participants should register here.

MSCA Postdoctoral Fellowships 2022 Call Information Webinar Series

The UK Research Office (UKRO), in its capacity as UK National Contact Point for the Horizon Europe Marie Skłodowska-Curie Actions (MSCA), will be holding a series of information webinars for organisations and individuals interested in applying to the 2022 MSCA Postdoctoral Fellowships Call (call opens 13 April 2022, call deadline 14 September 2022).

Postdoctoral Fellowships help experienced researchers advance their careers and gain new skills through training, international, intersectoral and international mobility. Postdoctoral Fellowships are aimed at researchers who are already in possession of a doctoral degree, and at the call deadline have a maximum of 8 years full-time equivalent research experience.

BU has excellent track record in applying for MSCA fellowships and we encourage those considering to apply for the first time to register and participate in these webinar series.

I would like to remind BU academics that MSCA calls are one of exceptions regarding submission of Intention to Bid forms; RDS my require to submit ItB up to two months before the submission deadline. Please get in touch with your RDS Funding Development Officer as soon as possible if you plan to apply to 2022 MSCA PF call.

ERC 2022 Advanced Grant Webinar Slides and Recording Available

The presentation slides and video recording from UKRO ERC Advanced Grant Webinar are now available for the two sessions and can be accessed on the UKRO event page.

Tentative Dates for ERC 2023 Calls are Announced

The European Research Council (ERC) has published the tentative deadline dates for the 2023 calls. Note that these deadlines will not be confirmed until the 2023 ERC Work Programme is officially published over the summer.

ERC calls are another exception regarding submission of ItB forms; RDS my require to submit ItB at least three months before the submission deadline. Please get in touch with your RDS Funding Development Officer as soon as possible if you plan to apply to ERC 2022 Advanced Grant or ERC 2023 Starting Grant (submission deadline in 2022) call.

I would like to also remind that all BU researchers can access the UKRO Portal as employees of the subscribing institution to read news articles, factsheets and other useful information. Anyone with an institutional email address can register. To access some links above, you may be required to be UKRO registered user.

Wessex REACH Initiative – ECR group discussion dates

Are you interested or involved in research?
Wessex REACH Initiative- training/mentorship/funding support

  • The Wessex REACH Initiative is an NIHR funded Incubator working to increase health and social care research capacity in the Wessex region. To help ensure that everyone has access to the training and support they need, we are undertaking a series of group discussions to explore experiences of accessing training/mentoring/funding opportunities. All discussions will be held online.
  • We would really like to speak to anyone who is in the early stage of their research career. You may be an early career researcher, a first time Principal or Lead Investigator or someone who has not held research funding previously but would like to.

    Available dates

  • Mar 21: 12pm-1pm
  • Mar 28: 10am-11am
  • Mar 29: 11am-12pm
  • Apr 4 : 1pm-2pm

    Expression of interest

Email your preferred date to info@wessexreach.org.uk

  • Further enquiries:

Eunice Aroyewun, info@wessexreach.org.uk

Request for feedback – MHRA clinical trials consultation

The Medicines & Healthcare products Regulatory Agency (the MHRA) have launched a public consultation into clinical trials.

The aim of the consultation is to streamline approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement.

There will be a 1 hour meeting on Monday 14th February at 1pm until 2pm, where you can offer your thoughts and feedback for BU’s institutional response.

If you wish to attend the meeting, please get in touch to be added to the invitation.

If you are unable to make the above time but wish to offer your thoughts, please email clinicalresearch@bournemouth.ac.uk to ensure your feedback is included.

Request for feedback – MHRA clinical trials consultation

The Medicines & Healthcare products Regulatory Agency (the MHRA) have launched a public consultation into clinical trials.

The aim of the consultation is to streamline approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement.

There will be a 1 hour meeting on Monday 14th February at 1pm until 2pm, where you can offer your thoughts and feedback for BU’s institutional response.

If you wish to attend the meeting, please get in touch to be added to the invitation.

If you are unable to make the above time but wish to offer your thoughts, please email clinicalresearch@bournemouth.ac.uk to ensure your feedback is included.